-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

Benzinga·08/06/2026 18:43:45
Listen to the news
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.